SAN DIEGO, California, November 17, 2015 /PRNewswire/ --
Regen BioPharma (OTCBB: RGBP) and (OTC Pink: RGBP) announced today the submission to the Food and Drug Administration (FDA) of data and responses to questions posed by the FDA with regards to HemaXellerate .
$BMSN/RGBP
All of my posts are honest, opinion based statements from due diligence performed by myself.